Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2 		0.310 GeneticVariation disease UNIPROT
Entrez Id: 5728
Gene Symbol: PTEN
PTEN 		0.300 Biomarker disease MGD
Entrez Id: 2176
Gene Symbol: FANCC
FANCC 		0.300 CausalMutation disease CGI
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1 		0.300 Biomarker disease MGD
Entrez Id: 2176
Gene Symbol: FANCC
FANCC 		0.300 GenomicAlterations disease CGI
Entrez Id: 79718
Gene Symbol: TBL1XR1
TBL1XR1 		0.300 CausalMutation disease CGI
Entrez Id: 23385
Gene Symbol: NCSTN
NCSTN 		0.200 Biomarker disease MGD
Entrez Id: 5395
Gene Symbol: PMS2
PMS2 		0.100 GeneticVariation disease CLINVAR
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1 		0.100 Biomarker disease BEFREE Thus, AHH acitivity or inducibility does not appear to be a major determinant of bladder cancer risk in humans. 437914 1979
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 Biomarker disease BEFREE A point mutation alters the 12th amino acid of the c-Ha-ras oncogene product p21 in a human bladder cancer cell line. 6304875 1983
Entrez Id: 3458
Gene Symbol: IFNG
IFNG 		0.100 Biomarker disease BEFREE Moreover, the results suggest that macrophages may be important regulators of IFN-gamma production in bladder cancer patients. 6426791 1984
Entrez Id: 2990
Gene Symbol: GUSB
GUSB 		0.020 AlteredExpression disease BEFREE Studies showing that bladder cancer patients have unusually high levels of urinary beta-glucuronidase and arylsulfatases A and B led to the suggestion that these urinary enzymes may participate in bladder cancer etiology. 6146401 1984
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 GeneticVariation disease BEFREE On the other hand, deletion of one Ha-ras allele was observed in 1 of 5 cases of bladder cancer and in 2 of 3 cases of renal pelvic cancer, suggesting that that deletion may be important in the development of urothelial cancer. 2889677 1987
Entrez Id: 3558
Gene Symbol: IL2
IL2 		0.390 Therapeutic disease CTD_human Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2. 3495671 1987
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1 		0.020 Biomarker disease BEFREE Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients. 3499374 1987
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 AlteredExpression disease BEFREE Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene. 3409229 1988
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 GeneticVariation disease BEFREE c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma. 2892780 1988
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 Biomarker disease CTD_human Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide. 2278634 1990
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.700 Biomarker disease CTD_human Oncogene expression of FANFT- or BBN-induced rat urothelial cells. 2228319 1990
Entrez Id: 4609
Gene Symbol: MYC
MYC 		0.400 Biomarker disease CTD_human Oncogene expression of FANFT- or BBN-induced rat urothelial cells. 2228319 1990
Entrez Id: 4609
Gene Symbol: MYC
MYC 		0.400 AlteredExpression disease BEFREE Detection of the c-myc gene product in urinary bladder cancer. 2125987 1990
Entrez Id: 3456
Gene Symbol: IFNB1
IFNB1 		0.310 Therapeutic disease CTD_human Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine. 2297754 1990
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.600 GeneticVariation disease BEFREE We examined 33 patients with renal cell carcinoma and 29 with bladder cancer; heterozygosity in the p53 gene was lost in 60% (6 of 10 cases) and 73% (8 of 11 cases) of the renal and bladder tumors, respectively. 2009130 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.600 GeneticVariation disease BEFREE The p53 mutations are the first genetic alterations demonstrated to occur in a high proportion of primary invasive bladder cancers. 2024123 1991
Entrez Id: 7124
Gene Symbol: TNF
TNF 		0.400 Therapeutic disease CTD_human Concomitant treatment of MBT-2 bladder tumour by tumour necrosis factor alpha and interferon alpha in conjunction with delayed type hypersensitivity immunotherapy. 1674182 1991